UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

2M33B

NL0014579062

Real-time Euronext Paris 08:52:36 06/05/2024 BST
3.75 EUR +0.81% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month-2.62%
1 month+9.41%
Date Price Change Volume
06/05/24 3.75 +0.81% 5
03/05/24 3.72 -1.85% 40
02/05/24 3.79 -0.79% 51
30/04/24 3.82 +0.79% 45
29/04/24 3.79 -1.81% 39

Real-time Euronext Paris

Last update May 06, 2024 at 08:52 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
2M33B
ISINNL0014579062
Date issued 17/03/2020
Strike 58.53 CHF
Maturity Unlimited
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.27
Lowest since issue 1.186

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.24 USD
Average target price
108.4 USD
Spread / Average Target
+11.52%
Consensus
  1. Stock Market
  2. Certificates
  3. 2M33B Certificat